$16.84 0.17 (+1.02%)
11/25/2009 4:00 PM

BioMarin Pharmaceutical, Inc. (BMRN)

CAPS Rating: 4 out of 5

The Company develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions.

Featured Broker Partners